E.A. Loeliger

2.7k total citations
85 papers, 1.7k citations indexed

About

E.A. Loeliger is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, E.A. Loeliger has authored 85 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 28 papers in Internal Medicine and 15 papers in Hematology. Recurrent topics in E.A. Loeliger's work include Atrial Fibrillation Management and Outcomes (32 papers), Venous Thromboembolism Diagnosis and Management (28 papers) and Antiplatelet Therapy and Cardiovascular Diseases (14 papers). E.A. Loeliger is often cited by papers focused on Atrial Fibrillation Management and Outcomes (32 papers), Venous Thromboembolism Diagnosis and Management (28 papers) and Antiplatelet Therapy and Cardiovascular Diseases (14 papers). E.A. Loeliger collaborates with scholars based in Netherlands, United Kingdom and Germany. E.A. Loeliger's co-authors include H.C. Hemker, J.J. Veltkamp, H. de Jonge, A.M.H.P. van den Besselaar, A Hensen, Axel R. Wintzen, G. Th. A. M. Bots, S. M. Lewis, R. Bieger and J. Hermans and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

E.A. Loeliger

81 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.A. Loeliger Netherlands 23 678 529 459 221 220 85 1.7k
P.T. Flute United Kingdom 21 456 0.7× 352 0.7× 639 1.4× 428 1.9× 511 2.3× 64 1.7k
Raymond Verhaeghe Belgium 20 536 0.8× 287 0.5× 436 0.9× 389 1.8× 931 4.2× 64 2.0k
Bruce A. Schwartz United States 18 454 0.7× 621 1.2× 481 1.0× 344 1.6× 366 1.7× 33 1.7k
C. Harold Mielke United States 19 508 0.7× 515 1.0× 225 0.5× 201 0.9× 379 1.7× 36 1.5k
E. Wenzel Germany 22 264 0.4× 427 0.8× 157 0.3× 266 1.2× 351 1.6× 110 1.5k
G A Marbet Switzerland 21 373 0.6× 335 0.6× 210 0.5× 284 1.3× 422 1.9× 62 1.4k
Steen Dalby Kristensen Denmark 22 1.0k 1.5× 270 0.5× 396 0.9× 141 0.6× 279 1.3× 63 1.6k
G. R. Fearnley United Kingdom 24 237 0.3× 374 0.7× 89 0.2× 446 2.0× 277 1.3× 65 1.7k
Ingvild Birschmann Germany 23 623 0.9× 400 0.8× 323 0.7× 144 0.7× 313 1.4× 70 1.7k
Thomas Vukovich Austria 21 356 0.5× 257 0.5× 254 0.6× 181 0.8× 440 2.0× 32 1.2k

Countries citing papers authored by E.A. Loeliger

Since Specialization
Citations

This map shows the geographic impact of E.A. Loeliger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.A. Loeliger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.A. Loeliger more than expected).

Fields of papers citing papers by E.A. Loeliger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.A. Loeliger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.A. Loeliger. The network helps show where E.A. Loeliger may publish in the future.

Co-authorship network of co-authors of E.A. Loeliger

This figure shows the co-authorship network connecting the top 25 collaborators of E.A. Loeliger. A scholar is included among the top collaborators of E.A. Loeliger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.A. Loeliger. E.A. Loeliger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Besselaar, A.M.H.P. van den, et al.. (1988). Long‐term stability of international reference preparations for thromboplastins. British Journal of Haematology. 68(3). 321–328. 4 indexed citations
5.
Broekmans, A.W. & E.A. Loeliger. (1987). Long-Term Anticoagulant Treatment After Acute Myocardial Infarction. PubMed. 214. 243–254. 2 indexed citations
6.
Loeliger, E.A. & S. M. Lewis. (1982). PROGRESS IN LABORATORY CONTROL OF ORAL ANTICOAGULANTS. The Lancet. 320(8293). 318–320. 31 indexed citations
7.
Loeliger, E.A.. (1981). Oral anticoagulation after myocardial infarction.. PubMed. 38. 87–95. 1 indexed citations
8.
Hermans, Jo, et al.. (1981). Prospective Double-blind Clinical Trial of Bovine, Human, and Rabbit Thromboplastins in Monitoring Long-term Oral Anticoagulation. American Journal of Clinical Pathology. 75(3). 297–303. 5 indexed citations
9.
Besselaar, A.M.H.P. van den, et al.. (1980). Simplified Thromboplastin Calibration: Further Experience of the Dutch Reference Laboratory for Anticoagulant Control. Thrombosis and Haemostasis. 43(1). 53–57. 6 indexed citations
10.
Tijssen, J. G. P., et al.. (1979). Het effect van het staken van langdurige antistollingbehandeling wegens myocardinfarct bij ouderen; een dubbelblind onderzoek. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 123(28). 1211–1212. 2 indexed citations
11.
Loeliger, E.A., et al.. (1978). Successful prevention of coumarin-induced hemorrhagic skin necrosis by timely administration of vitamin K1. Annals of Hematology. 36(2). 89–93. 15 indexed citations
12.
Loeliger, E.A., et al.. (1978). The Preparation of Control Blood for External Quality Assessment Programs in Oral Anticoagulant Control. Thrombosis and Haemostasis. 39(1). 210–214. 9 indexed citations
13.
Loeliger, E.A., et al.. (1977). Qualit�tskontrolle und Standardisierung der Prothrombinzeitbestimmung zur Kontrolle oraler Antikoagulation. Annals of Hematology. 34(2). 147–157. 1 indexed citations
14.
Loeliger, E.A., et al.. (1975). Standardisierung des quick-testes referenz-thromboplastine oder referenz-plasmen. Annals of Hematology. 30(1). 62–63. 1 indexed citations
15.
Loeliger, E.A., et al.. (1975). External Quality Control in The Netherlands. Thrombosis and Haemostasis. 33(3). 667–667. 1 indexed citations
16.
Hemker, H.C., et al.. (1971). Additional Evidence for the Existence of a Precursor Molecule of the Prothrombin Complex in Oral Anticoagulation. Thrombosis and Haemostasis. 25(2). 312–315. 7 indexed citations
17.
Bruning, P.F. & E.A. Loeliger. (1971). Prothrombal: A New Concentrate of Human Prothrombin Complex for Clinical Use. British Journal of Haematology. 21(4). 377–398. 23 indexed citations
18.
Loeliger, E.A., Margarete Mattern, A Hensen, & H.C. Hemker. (1968). Behandlung der Hämophilie B mit PPSB. Annals of Hematology. 16(5). 289–297.
19.
Hemker, H.C., J.J. Veltkamp, & E.A. Loeliger. (1968). Kinetic aspects of the interaction of blood clotting enzymes. 3. Demonstration of an inhibitor of prothrombin conversion in vitamin K deficiency.. PubMed. 19(3). 346–63. 54 indexed citations
20.
Veltkamp, J.J., E.A. Loeliger, & H.C. Hemker. (1965). The Biological Half-Time of Hageman Factor. Thrombosis and Haemostasis. 13(1). 1–7. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026